Joeri Lambrecht

1.5k total citations · 1 hit paper
26 papers, 1.0k citations indexed

About

Joeri Lambrecht is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Joeri Lambrecht has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 10 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Joeri Lambrecht's work include Liver Disease Diagnosis and Treatment (14 papers), Liver physiology and pathology (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). Joeri Lambrecht is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver physiology and pathology (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). Joeri Lambrecht collaborates with scholars based in Germany, Belgium and United States. Joeri Lambrecht's co-authors include Frank Tacke, Cynthia Ju, Yankai Wen, Leo A. van Grunsven, Inge Mannaerts, Stefaan Verhulst, Hendrik Reynaert, H. Wieland, D. Seidel and Bruno Agostini and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Joeri Lambrecht

25 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities

2020 456 citations Yankai Wen, Joeri Lambrecht et al. Cellular and Molecular Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joeri Lambrecht Germany	15	560	430	251	187	168	26	1.0k
Xiaodong Ge United States	17	631 1.1×	432 1.0×	425 1.7×	159 0.9×	215 1.3×	40	1.5k
Oriol Morales‐Ibanez Spain	11	768 1.4×	467 1.1×	286 1.1×	151 0.8×	200 1.2×	14	1.3k
Suxian Zhao China	19	630 1.1×	374 0.9×	429 1.7×	114 0.6×	168 1.0×	58	1.2k
Terumi Takahara Japan	22	409 0.7×	402 0.9×	395 1.6×	170 0.9×	302 1.8×	65	1.4k
Natascha Roehlen Germany	9	561 1.0×	519 1.2×	274 1.1×	73 0.4×	210 1.3×	15	1.1k
Annette Grambihler Germany	12	540 1.0×	419 1.0×	556 2.2×	170 0.9×	170 1.0×	19	1.3k
Bedair Dewidar Germany	8	764 1.4×	689 1.6×	420 1.7×	123 0.7×	244 1.5×	16	1.4k
Qinghua Meng China	19	734 1.3×	605 1.4×	334 1.3×	149 0.8×	136 0.8×	70	1.4k
Yuemin Nan China	23	997 1.8×	670 1.6×	508 2.0×	113 0.6×	180 1.1×	117	1.6k
Shufei Zang China	18	529 0.9×	163 0.4×	331 1.3×	161 0.9×	108 0.6×	46	1.1k

Countries citing papers authored by Joeri Lambrecht

Since Specialization

Citations

This map shows the geographic impact of Joeri Lambrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joeri Lambrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joeri Lambrecht more than expected).

Fields of papers citing papers by Joeri Lambrecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joeri Lambrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joeri Lambrecht. The network helps show where Joeri Lambrecht may publish in the future.

Co-authorship network of co-authors of Joeri Lambrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Joeri Lambrecht. A scholar is included among the top collaborators of Joeri Lambrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joeri Lambrecht. Joeri Lambrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lambrecht, Joeri, et al.. (2023). Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression. International Journal of Molecular Sciences. 24(6). 5295–5295. 6 indexed citations

Maaß, Christian, Madalena Cipriano, Joeri Lambrecht, et al.. (2022). Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics. Open Biology. 12(3). 210333–210333. 33 indexed citations

Geisler, Lukas, Joeri Lambrecht, Henning Jann, et al.. (2022). Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors. Journal of Clinical Medicine. 11(20). 6191–6191. 5 indexed citations

Geisler, Lukas, Raphael Mohr, Joeri Lambrecht, et al.. (2021). The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors. International Journal of Molecular Sciences. 22(16). 8569–8569. 13 indexed citations

Mohr, Raphael, Burcin Özdirik, Joeri Lambrecht, et al.. (2021). From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. International Journal of Molecular Sciences. 22(3). 1492–1492. 21 indexed citations

Mohr, Raphael, Burcin Özdirik, Joeri Lambrecht, et al.. (2021). Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma. Frontiers in Immunology. 12. 652172–652172. 23 indexed citations

Lambrecht, Joeri & Frank Tacke. (2021). Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. Frontiers in Immunology. 11. 634409–634409. 30 indexed citations

Mohr, Raphael, Lukas Geisler, Alexander Wree, et al.. (2020). Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors. PLoS ONE. 15(12). e0244504–e0244504. 4 indexed citations

Wen, Yankai, Joeri Lambrecht, Cynthia Ju, & Frank Tacke. (2020). Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cellular and Molecular Immunology. 18(1). 45–56. 456 indexed citations breakdown →

10.

Lambrecht, Joeri, Leo A. van Grunsven, & Frank Tacke. (2020). Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis. Expert Opinion on Pharmacotherapy. 21(13). 1637–1649. 48 indexed citations

11.

Lambrecht, Joeri, Stefaan Verhulst, Inge Mannaerts, et al.. (2019). A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease. EBioMedicine. 43. 501–512. 31 indexed citations

12.

Lambrecht, Joeri, Stefaan Verhulst, Inge Mannaerts, Hendrik Reynaert, & Leo A. van Grunsven. (2018). Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1024–1036. 42 indexed citations

13.

Lambrecht, Joeri, et al.. (2017). Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis. Frontiers in Pharmacology. 8. 56–56. 39 indexed citations

14.

Lambrecht, Joeri, Inge Mannaerts, & Leo A. van Grunsven. (2015). The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. Frontiers in Physiology. 6. 209–209. 34 indexed citations

15.

Coll, Mar, Adil El Taghdouini, Luís Perea, et al.. (2015). Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells. Scientific Reports. 5(1). 11549–11549. 74 indexed citations

16.

Filippi, Andreas, et al.. (2006). [The "globulomaxillary cyst" a specific entity or a myth?].. PubMed. 116(4). 380–97. 3 indexed citations

17.

Bornstein, Michael M., et al.. (2005). [The odontogenic keratocyst--odontogenic cyst or benign tumor?].. PubMed. 115(2). 110–28. 8 indexed citations

18.

Michotte, Yvette, et al.. (1981). High-performance liquid chromatographic determination of papaverine in whole blood. Journal of Chromatography B Biomedical Sciences and Applications. 226(2). 423–430. 10 indexed citations

19.

Müller, Pierre, R. Fellin, Joeri Lambrecht, et al.. (1974). Hypertriglyceridaemia Secondary to Liver Disease. European Journal of Clinical Investigation. 4(6). 419–428. 28 indexed citations

20.

Müller, Pierre, R. Fellin, Joeri Lambrecht, et al.. (1974). Hypertriglyceridaemia Secondary to Liver Disease. European Journal of Clinical Investigation. 4(1). 419–428. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact